Search research articles
Contact Us
Filters
Showing results (51-60 of 274) with videos related to
Page
of 28
Sort By:
Physical Medicine and Rehabilitation Clinics of North America
|
May 16, 2000
Potential applications of gene therapy in sports medicine
C H Evans, S C Ghivizzani, P D Robbins
Nature
|
August 16, 1990
Negative regulation of human c-fos expression by the retinoblastoma gene product
P D Robbins, J M Horowitz, R C Mulligan
Gene Therapy
|
January 16, 2004
Gene therapy approaches for osteogenesis imperfecta
C Niyibizi, S Wang, Z Mi, et al.
Biochemical and Biophysical Research Communications
|
May 16, 1994
A sustained, cytoplasmic transgene expression system delivered by cationic liposomes
X Gao, D Jaffurs, P D Robbins, et al.
Idrugs : the Investigational Drugs Journal
|
May 10, 2008
Gene therapy in arthritis
J D Whalen, P D Robbins, C H Evans
Journal of Cellular Physiology
|
September 28, 2011
Orthopedic gene therapy--lost in translation?
C H Evans, S C Ghivizzani, P D Robbins
Methods in Molecular Biology (Clifton, N.J.)
|
May 3, 2000
Methods for constructing and producing retroviral vectors
A Gambotto, S H Kim, S Kim, et al.
The Journal of Biological Chemistry
|
September 1, 2000
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor
N Giannoukakis, W A Rudert, M Trucco, et al.
Gene Therapy
|
February 4, 1999
The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site
J Byun, J M Kim, P D Robbins, et al.
Oncogene
|
July 24, 1997
Rb interacts with TAF(II)250/TFIID through multiple domains
Z Shao, J L Siegert, S Ruppert, et al.
Page
of 28
Search research articles
Search
Showing results (51-60 of 274) with videos related to
Sort By:
Page
of 28
Physical Medicine and Rehabilitation Clinics of North America
|
May 16, 2000
Potential applications of gene therapy in sports medicine
C H Evans, S C Ghivizzani, P D Robbins
Nature
|
August 16, 1990
Negative regulation of human c-fos expression by the retinoblastoma gene product
P D Robbins, J M Horowitz, R C Mulligan
Gene Therapy
|
January 16, 2004
Gene therapy approaches for osteogenesis imperfecta
C Niyibizi, S Wang, Z Mi, et al.
Biochemical and Biophysical Research Communications
|
May 16, 1994
A sustained, cytoplasmic transgene expression system delivered by cationic liposomes
X Gao, D Jaffurs, P D Robbins, et al.
Idrugs : the Investigational Drugs Journal
|
May 10, 2008
Gene therapy in arthritis
J D Whalen, P D Robbins, C H Evans
Journal of Cellular Physiology
|
September 28, 2011
Orthopedic gene therapy--lost in translation?
C H Evans, S C Ghivizzani, P D Robbins
Methods in Molecular Biology (Clifton, N.J.)
|
May 3, 2000
Methods for constructing and producing retroviral vectors
A Gambotto, S H Kim, S Kim, et al.
The Journal of Biological Chemistry
|
September 1, 2000
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor
N Giannoukakis, W A Rudert, M Trucco, et al.
Gene Therapy
|
February 4, 1999
The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site
J Byun, J M Kim, P D Robbins, et al.
Oncogene
|
July 24, 1997
Rb interacts with TAF(II)250/TFIID through multiple domains
Z Shao, J L Siegert, S Ruppert, et al.
Page
of 28